Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...
Zacks.com on MSN
Should You Continue to Hold DGX Stock in Your Portfolio?
Quest Diagnostics DGX is well-poised to grow in the coming quarters owing to its investments in advanced diagnostics to deliver and scale innovative services. The company’s growth strategy includes ...
The news comes one week after Boston-based Whoop announced broader plans to expand the business, including by increasing its staff by as much as 75 percent this year.
MindImmune today announced a transformative $5 million award from the Alzheimer's Drug Discovery Foundation (ADDF) to accelerate development of its lead therapeutic candidate, MITI-101 ? a ...
The Maine Monitor on MSN
Few Mainers are getting tested for PFAS despite state push
The 164 positive tests the state has collected since last fall likely represent a fraction of the people exposed to high PFAS levels.
If you’re a Whoop member, you can expect to see two new women’s health updates for both hormonal insights and blood panels.
Eating Protein Saves Lives, Inc. a leader in nutritional approaches to addiction treatment and recovery, announces the launch ...
Stockhead on MSN
Health Check: Rhythm Biosciences is in the groove with first commercial sale of its bowel cancer assay
Rhythm Biosciences is entering a new commercial era, following the first sale of its revolutionary Colostat bowel cancer assay. ... Read More The post Health Check: Rhythm Biosciences is in the groove ...
Expedition 74 crew members, aboard the International Space Station (ISS), are gearing up for a pivotal spacewalk while ...
AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which just raised $1 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results